Market Overview

'A Larger, More Efficient Scale': About BDS Anaytics' $7-Million Raise

Share:
'A Larger, More Efficient Scale': About BDS Anaytics' $7-Million Raise
Read more about our latest Cannabis News! CANNABIS HOME

Cannabis market intelligence and consumer research company BDS Analytics announced the closing of an initial $7-million fundraising round on Tuesday. 

The capital will be used to scale the company alongside the growing global cannabis industry, expanding the company's capability ccommodate the entire addressable cannabinoid market, BDS said in a press release. The round was led by KEY Investment Partners, Altitude Investment Management and 7Thirty.

Don’t miss out on the top cannabis stories of the day. Click here to sign up for our daily insider newsletter.

“Businesses across all industries rely on data and analytics to make informed decisions, and as the cannabis market grows, so must our technology and capabilities,” CEO Roy Bingham said in a statement. 

“The industry’s forward momentum reaffirms the indispensable nature of our insights to help companies and industry leaders better serve their customers, and we look forward to continuing this work at a larger, more efficient scale.”

Additionally, Micah Tapman, managing partner and co-founder at 7Thirty, has been appointed chairman of BDS Analytics.

Tapman will use his background in technology to guide the next generation of innovation and operational efficiencies.

Pete Karabas of KEY Investment Partners will also be joining BDS Analytics’ board.

Click here for more information about the upcoming Benzinga Cannabis Capital Conference Oct. 22-23 in Chicago.

Read more about our latest Cannabis News! CANNABIS HOME

Posted-In: BDS Analytics marijuana pot weedCannabis News Financing Markets Best of Benzinga

 

Related Articles

View Comments and Join the Discussion!

Cannabis Movers

Sign up for our secret cannabis newsletter!
Never miss out on the breaking news in the Cannabis Industry!

Earnings Scheduled For August 26, 2019

The Week Ahead In Biotech: A Quiet One Ahead Of Labor Day Weekend